AI brief of an SEC Form 8-K · ARTS WAY MANUFACTURING CO INC (ARTW)

Art's-Way Q3 net loss of $140,000 as sales fell 12.7%; nine-month sales up 12.3%

Mixed Impact 4 of 5 earnings Written later

Art's-Way Manufacturing reported third-quarter fiscal 2026 sales of $5,615,000, down from $6,432,000, and a net loss of $140,000, compared with net income of $254,000 a year earlier. For the first nine months, sales rose to $20,110,000 from $17,910,000, but net income fell to $230,000 from $1,680,000, and nine-month EPS dropped to $0.04 from $0.33. The company also took a $956,000 term loan from Bank Midwest to buy a new fiberoptic laser and crane system.

Key points

  • Q3 (three months ended August 31, 2026): sales $5,615,000 vs. $6,432,000; net loss $140,000 vs. net income $254,000; EPS $(0.03) vs. $0.05
  • Nine months ended August 31, 2026: sales $20,110,000 vs. $17,910,000; net income $230,000 vs. $1,680,000; EPS $0.04 vs. $0.33
  • Management cited rising material and operating costs pressuring margins, and a prior-year Employee Retention Credit that did not repeat in fiscal 2026
  • Laser Loan of $956,000 dated October 5, 2026; 6.65% fixed for the first 60 payments, then 1-month SOFR plus 3.1%; initial monthly payment $8,456

The filing

CompanyARTS WAY MANUFACTURING CO INC (ARTW)
Form8-K, current report
Filed with the SECOct 9, 2026, 1:05 PM ET
Accession number0001437749-26-032423

Items reported: 1.01 Material Definitive Agreement2.02 Results of Operations2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 09, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.